Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
Clinical trial NCT02273362 · COMPLETED
Trial details
- NCT number
- NCT02273362
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2020-02-11
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.